PL377601A1 - Sposoby przewidywania zachowania samobójczego podczas leczenia - Google Patents
Sposoby przewidywania zachowania samobójczego podczas leczeniaInfo
- Publication number
- PL377601A1 PL377601A1 PL377601A PL37760104A PL377601A1 PL 377601 A1 PL377601 A1 PL 377601A1 PL 377601 A PL377601 A PL 377601A PL 37760104 A PL37760104 A PL 37760104A PL 377601 A1 PL377601 A1 PL 377601A1
- Authority
- PL
- Poland
- Prior art keywords
- prediction
- methods
- during treatment
- suicidality during
- suicidality
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/9413—Dopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44901803P | 2003-02-21 | 2003-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL377601A1 true PL377601A1 (pl) | 2006-02-06 |
Family
ID=32908683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL377601A PL377601A1 (pl) | 2003-02-21 | 2004-02-20 | Sposoby przewidywania zachowania samobójczego podczas leczenia |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070065821A1 (pl) |
EP (1) | EP1597392A1 (pl) |
JP (1) | JP2006518206A (pl) |
CN (1) | CN1754000A (pl) |
AU (1) | AU2004213582A1 (pl) |
CA (1) | CA2516484A1 (pl) |
MX (1) | MXPA05008793A (pl) |
PL (1) | PL377601A1 (pl) |
WO (1) | WO2004074513A1 (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090281090A1 (en) * | 2004-06-04 | 2009-11-12 | Novartis Ag | Biomarkers for the prediction of responsiveness to clozapine treatment |
US8930178B2 (en) | 2007-01-04 | 2015-01-06 | Children's Hospital Medical Center | Processing text with domain-specific spreading activation methods |
EP2149047A4 (en) * | 2007-04-30 | 2010-05-19 | Univ Ohio State Res Found | POLYMORPHISMS IN GENES WITH INFLUENCE ON DOPAMINTRANSPORTER DISEASES AND ITS APPLICATIONS |
WO2008144371A1 (en) * | 2007-05-16 | 2008-11-27 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for diagnosing suicidal tendencies |
EP3522172B1 (en) | 2009-04-27 | 2021-10-20 | Children's Hospital Medical Center | Method for assessing a neuropsychiatric condition of a human subject |
WO2011119227A2 (en) * | 2010-03-25 | 2011-09-29 | Columbia Northwest Pharmaceuticals, Llc | Compositions for the treatment of central nervous system disorders including depression employing novel drug combination therapy to reduce suicidality in patients |
JP6061935B2 (ja) * | 2011-09-14 | 2017-01-18 | ザ ヘンリー エム. ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン,インコーポレーテッド | 心的外傷後ストレス障害(ptsd)のための診断用バイオマーカーを検出及び監視するため、並びに同障害の自殺型と非自殺型とを識別するためのプロセス及びキット |
FR2993889B1 (fr) | 2012-07-27 | 2014-08-22 | Michelin & Cie | Composition de caoutchouc thermo-expansible pour pneumatique |
US9938576B1 (en) | 2012-09-21 | 2018-04-10 | Ohio State Innovation Foundation | Materials and methods for determining metabolizer status in humans |
WO2014201515A1 (en) * | 2013-06-18 | 2014-12-24 | Deakin University | Medical data processing for risk prediction |
CA2918054C (en) | 2013-07-11 | 2022-12-13 | The Johns Hopkins University | A dna methylation and genotype specific biomarker of suicide attempt and/or suicide ideation |
FR3009306B1 (fr) | 2013-07-30 | 2015-07-31 | Michelin & Cie | Pneu dont la zone sommet est pourvue d’une couche interne reduisant les bruits de roulage |
FR3009305A1 (fr) | 2013-07-30 | 2015-02-06 | Michelin & Cie | Composition de caoutchouc thermo-expansible et pneumatique comportant une telle composition |
-
2004
- 2004-02-20 EP EP04713011A patent/EP1597392A1/en not_active Withdrawn
- 2004-02-20 CA CA002516484A patent/CA2516484A1/en not_active Abandoned
- 2004-02-20 PL PL377601A patent/PL377601A1/pl not_active Application Discontinuation
- 2004-02-20 JP JP2006501914A patent/JP2006518206A/ja active Pending
- 2004-02-20 MX MXPA05008793A patent/MXPA05008793A/es not_active Application Discontinuation
- 2004-02-20 CN CNA200480004872XA patent/CN1754000A/zh active Pending
- 2004-02-20 WO PCT/EP2004/001692 patent/WO2004074513A1/en not_active Application Discontinuation
- 2004-02-20 AU AU2004213582A patent/AU2004213582A1/en not_active Abandoned
- 2004-02-20 US US10/545,695 patent/US20070065821A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004074513A1 (en) | 2004-09-02 |
JP2006518206A (ja) | 2006-08-10 |
MXPA05008793A (es) | 2006-02-22 |
CA2516484A1 (en) | 2004-09-02 |
CN1754000A (zh) | 2006-03-29 |
EP1597392A1 (en) | 2005-11-23 |
US20070065821A1 (en) | 2007-03-22 |
AU2004213582A1 (en) | 2004-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200508427B (en) | Methods for treating interleuking-6 related diseases | |
IL174014A0 (en) | Methods for the treatment of endometriosis | |
EP1613308A4 (en) | CANCER TREATMENT METHODS | |
ZA200504558B (en) | Compounds for the treatment of metabolic disorders | |
EG24420A (en) | Treatment of ophthalmic conditions | |
AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
EP1635813A4 (en) | COMBINATION THERAPY FOR THE TREATMENT OF DYSLIPIDEMIA | |
EP1635763A4 (en) | METHOD FOR TREATING NEURODEEGENERATIVE ILLNESSES | |
EP1643986A4 (en) | PHENYLCARBOXYLATE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
GB0320238D0 (en) | Treatment of disease | |
PL377601A1 (pl) | Sposoby przewidywania zachowania samobójczego podczas leczenia | |
EP1651237A4 (en) | METHOD FOR THE TREATMENT OF DERMATOLOGICAL ILLNESSES | |
EP1667827A4 (en) | PROCESS FOR TREATING WOOD | |
GB0306309D0 (en) | Method of treatment | |
GB0302572D0 (en) | Method of treatment | |
GB0221712D0 (en) | Methods of treatment | |
EP1648469A4 (en) | ANTIGLUCOCORTICOIDES FOR THE TREATMENT OF CATATONIA | |
GB0327975D0 (en) | Methods of treatment | |
GB0307544D0 (en) | Treatment method | |
GB0302691D0 (en) | Treatment method | |
GB0702858D0 (en) | Dressinf for tissue treatment | |
GB0322921D0 (en) | Methods of treatment | |
GB0325259D0 (en) | Therapeutic agents for the treatment of bone conditions | |
GB0310463D0 (en) | Therapeutic agents for the treatment of bone conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |